Custom cell culture media: when to commission your own formulation
Custom media is commissioned for one of three reasons: a catalogue formulation does not support the cells well enough, a component has to be removed for regulatory or supply reasons, or the volume makes a bespoke blend cheaper than a catalogue product. Only the first is a science question, and it is worth being clear which of the three is driving the project before starting. This page covers the decision, the format and the terms.
- the FDA cGMP rule that applies once material is destined for a drug product
- Part 211
- the ICH guideline on deriving and characterising cell substrates
- Q5D
- good laboratory practice for nonclinical studies, 21 CFR
- Part 58
Figures in this panel are the rules a contract biologics service is bought and audited against, named from the regulations and guidelines themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a services index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Commissioning a formulation
- Be clear which problem you are solving. Performance, composition control and cost lead to different projects. A performance project needs a development programme with screening; a composition project may be a straightforward removal or substitution; a cost project is a procurement exercise on a formulation you already have.
- Liquid or powder. Liquid is convenient and heavy to ship and store, with a shorter shelf life. Powder stores far longer and needs water quality, mixing and filtration capability plus the validation that goes with them. Volume and in-house capability decide this rather than preference.
- Raw material sourcing and traceability. Ask where components originate, whether any are animal derived, and what traceability the provider holds. For anything that may become a regulated process, animal origin components are a question that will be asked and is far easier to avoid than to justify.
- Formulation ownership. Establish who owns the formulation and whether you can have it made elsewhere. A bespoke medium you do not own is a single-source dependency for the life of the process, which is a serious position for a programme that succeeds.
- Lot control and bridging. Agree lot sizes, retention samples and what happens when a component supplier changes. Media lot variation is a classic invisible cause of drifting culture performance, and it is only detectable if you kept a reference and recorded which lot produced which result.
Before commissioning, exhaust the catalogue
Modern catalogue media are extensively developed, and a supplement screen on an existing formulation solves many performance problems at a fraction of the cost and time of a custom development. Providers will often run that screen for you.
Where the catalogue genuinely fails, the development is worth doing properly with a defined success criterion agreed in advance. Media projects without a stated target tend to continue indefinitely.
Testing what arrives
Test each lot in your own culture against a retained reference lot before committing it to production or to a long experiment. Growth, viability and the product attributes you care about are the test, not the certificate alone.
Keep retention samples of every lot. They are the only way to investigate afterwards whether a change in culture behaviour came from the medium.
What a cell culture medium is made of: basal medium and supplements
A basal formulation supplies salts, amino acids, vitamins and a carbon source, and on its own supports almost nothing. Serum, defined supplements, glutamine or a stable dipeptide equivalent and any tissue specific additions are what make a medium usable, and each is a variable in its own right.
Formulations differ mainly in glucose concentration, buffering and amino acid content, and cells adapted to one do not always transfer cleanly to another. Change medium deliberately, with an overlap period, and record the change; an unexplained shift in growth after a reorder is usually a formulation difference rather than biology.
HEPES for cell culture: the price of stability outside the incubator
Most media are buffered by bicarbonate in equilibrium with the incubator's atmosphere, which is why the pH drifts as soon as a flask sits on a bench. An organic buffer added to the medium holds pH outside the incubator and makes imaging and long manipulations practical.
It is not free: it can be toxic to some cells at higher concentrations, it can contribute to light induced toxicity during imaging, and it changes the medium's osmolality. Add it for the work that needs it, at the lowest concentration that does the job, rather than to every bottle by default.
Antibiotics, contamination and what routine use hides
Routine antibiotic use suppresses the visible symptoms of poor technique while selecting for resistant organisms and masking low-level contamination, including the one contaminant that matters most and cannot be seen. A laboratory that cultures without antibiotics finds its technique problems immediately.
The defensible positions are to work without them and fix the technique, or to use them for a defined purpose such as primary isolation or a selection, with a plan to withdraw. Using them permanently because everyone does is the position that leads to a contaminated bank nobody detected.
Surfaces, coatings and the cell culture matrix adherent cells need
Many cells will not attach or will not behave normally on untreated plastic, and a coating is then part of the culture system. A synthetic polycation coating provides charge for attachment; an extracellular matrix preparation provides ligands the cells actually signal through.
They are not interchangeable and the second varies substantially between batches. Record the coating, its concentration and its lot alongside the medium, because a change in any of them is a change in the experiment and it is the usual cause of a morphology that shifts after a reorder.
Cell culture media filtration, and what a rating means
Sterilising filtration removes bacteria and fungi and does not remove mycoplasma or virus, so a filtered medium is sterile in one sense and not in another. The rating describes the retention of a specified organism under specified conditions rather than a hole size.
Filters also bind protein, which matters when the medium contains an expensive growth factor. Where a component is precious, check the binding characteristics of the membrane and consider filtering the basal medium before the component is added.
ypd media, and where a defined medium replaces it
YPD is yeast extract, peptone and dextrose: a rich undefined medium that grows most yeast quickly and is what a laboratory pours for propagation, transformation recovery and plates. It is undefined by construction, so the nitrogen and vitamin content moves between lots, which is why an expression experiment that has to be comparable run to run moves to a synthetic defined medium with the specific dropouts a selection needs. Keep YPD for growth and recovery, use defined medium wherever a selection, a metabolic measurement or a yield figure has to be reproduced.
Keratinocyte media, and why it is unusual
Keratinocytes are calcium sensitive: low calcium keeps them proliferating and raising it drives differentiation, which is why their media come in defined low calcium formulations with a separate supplement set rather than as serum-containing mixtures. Serum itself pushes differentiation, so the media are usually serum free with epidermal growth factor and insulin added, and the substrate matters, coated or feeder-supported for primary cells. Any comparison between experiments has to state the calcium concentration, because it is the variable that decides the phenotype.
Common questions
- When are custom media for cell culture worth commissioning?
- When catalogue formulations and a supplement screen genuinely fail to support the cells, when a component must be removed for regulatory or supply reasons, or when volume makes a bespoke blend cheaper. Exhaust the catalogue first.
- Liquid or powder cell media?
- Liquid for convenience at modest volumes; powder for long storage and large volumes, provided you have the water quality, mixing and filtration capability and the validation to match.
- Who owns a custom formulation?
- Whatever the contract says. If you do not own it or cannot have it made elsewhere, the medium is a single-source dependency for the life of the process.
- How do I control media lot variation?
- Test each new lot against a retained reference in your own culture, keep retention samples, and record which lot produced which result. Lot variation is otherwise invisible and easily mistaken for an experimental effect.
- Should antibiotics be routine in culture medium?
- No. Routine use masks poor technique and low-level contamination, including mycoplasma, and selects for resistance. Use them for a defined purpose such as primary isolation or a selection, and work without them otherwise.
- Why did my cells change after a media reorder?
- Most often a formulation, serum lot or coating batch difference. Record the formulation, the serum lot and any coating with its batch, and change medium deliberately with an overlap rather than at the bottle.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/custom-cell-culture-media/.